S100A1 and rheumatoid arthritis: Moreover, tofacitinib redirected RA blood and synovial IL1β+S100A+HIF1+IL10loNFIL3/6loMΦs into a regulatory phenotype, reversing oxidative stress and mitochondrial fragmentation.